In a recent study that could transform the way we manage varicose veins, researchers have unveiled an exciting alternative to traditional treatments. The study, conducted by a team of experts including Nada Elzefzaf, Mohamed A Elfeky, Kareem M Elshatlawy, Ahmed Abdelal, Abdelaziz Elhendawy, Abdelrahman Ahmed, Mohamed Nada, and Tarek Ouf, focuses on the potential of endovenous laser ablation (EVLA).
For over a century, conventional treatments like high ligation of the saphenofemoral junction (SFJ) and stripping of the great saphenous vein (GSV) have been the go-to methods for managing GSV insufficiency, especially in North African surgical centers. However, modern medicine is rapidly shifting towards minimally invasive alternatives, such as endovenous thermal ablation (EVTA), radiofrequency ablation (RFA), ultrasound-guided foam sclerotherapy, and cryo-stripping. These approaches have delivered excellent results and high patient satisfaction.
The researchers conducted a clinical and prospective study involving 30 individuals with primary varicose veins. The results were promising, with patients expressing satisfaction with the outcomes. Crucially, the study reported no major complications, such as vein recurrence or recanalization, following EVLA. Minor complications included manageable bruising, postoperative pain, superficial thrombophlebitis, and treatable skin burns, underlining the overall safety of the procedure.
Endovenous laser ablation (EVLA) is emerging as an appealing, minimally invasive solution for varicose vein treatment. Not only does it offer minimal risk, but it also boasts a quick recovery period, making it an attractive choice for patients. This research by Nada Elzefzaf, Mohamed A Elfeky, Kareem M Elshatlawy, Ahmed Abdelal, Abdelaziz Elhendawy, Abdelrahman Ahmed, Mohamed Nada, and Tarek Ouf underscores the potential of EVLA and the importance of staying informed about evolving treatments for venous disorders.
To explore this study in greater detail, you can access the full research here.